Hemorrhagic Proctocolitis Clinical Trials

Find Hemorrhagic Proctocolitis Clinical Trials Near You

Measurement of Basal Metabolism in Patients With Crohn's Disease and Ulcerative Colitis and Correlation With Disease Activity.

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This multicenter prospective observational non-pharmacological study aims to evaluate resting energy expenditure (REE) in pediatric patients affected by inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. REE will be measured using indirect calorimetry and estimated using predictive equations. The study also aims to investigate the relationship between REE, disease activity, and dietary or pharmacological treatments. Clinical, laboratory, anthropometric, nutritional, and disease activity data will be collected during routine clinical follow-up at diagnosis, after induction therapy, and during follow-up visits.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 17
Healthy Volunteers: f
View:

• Pediatric patients aged 6 to 17 years

• New diagnosis of inflammatory bowel disease, including Crohn disease or ulcerative colitis, according to ECCO/ESPGHAN criteria

• Written informed consent signed by parents or legal guardians

Locations
Other Locations
Italy
Pediatric Unit
RECRUITING
Alessandria
Contact Information
Primary
Clinical Trial Center (CTC)
clinicaltrialcenter@ospedale.al.it
0131206893
Time Frame
Start Date: 2025-05-01
Estimated Completion Date: 2027-11
Participants
Target number of participants: 50
Treatments
Pediatric IBD Patients
Pediatric patients aged 6 to 17 years with a new diagnosis of inflammatory bowel disease, including Crohn disease and ulcerative colitis, enrolled in this prospective multicenter observational study. Participants undergo resting energy expenditure assessment by indirect calorimetry together with routine clinical, laboratory, anthropometric, nutritional, and disease activity evaluations during follow-up.
Sponsors
Leads: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

This content was sourced from clinicaltrials.gov